Cetuximab for NSCLC, from ASCO 2008
27 Nov 2008
Cetuximab for NSCLC, from ASCO 2008
Cetuximab for metastatic colorectal cancer (mCRC), from ASCO 2008
Cetuximab and docetaxal for squamous cell cancer of the head and neck, from ASCO 2008
Highlights and headlines anticipated at the joint ECCO 15 - 34th ESMO Multidisciplinary Congress
EBCC 6: Conference highlights from Europa Donna